More stories

  • in

    Stocks making the biggest moves in the premarket: Big banks, Facebook, Tesla & more

    Take a look at some of the biggest movers in the premarket:Big banks – Goldman Sachs (GS), Bank of America (BAC), Morgan Stanley (MS), JPMorgan Chase (JPM) and Wells Fargo (WFC) all announced dividend increases after passing the Fed’s latest stress tests. Morgan Stanley and Wells Fargo both doubled their dividends, while Citigroup (C) was the only one of the six largest banks to keep its dividend unchanged. Morgan Stanley rose 3.3% in the premarket, with Goldman up 1.4%.Facebook (FB) – Facebook remains on watch after a late Monday jump which saw it surge past the $1 trillion mark in market value. That followed a court decision that dismissed both federal and state antitrust complaints against the social media giant.Tesla (TSLA) – UBS cut its price target on Tesla shares to $660 from $730, while maintaining a “neutral” rating, noting increasing competition as well as operational delays.Boeing (BA) – Boeing won a 200 jet order from United Airlines (UAL), which also ordered 70 Airbus jets as it modernizes its fleet. United will buy a variety of Max jets from Boeing and A321neo models from Airbus.FactSet (FDS) – The financial information company earned $2.72 per share for its fiscal third quarter, 3 cents a share shy of estimates. Revenue came in above Wall Street forecasts. FactSet expects earnings of $10.75 to $11.15 per share for the fiscal year ending in August, compared to a current consensus estimate of $11.14 a share.Herman Miller (MLHR) – Herman Miller reported quarterly profit of 56 cents per share, beating the consensus estimate of 39 cents a share. The office furniture maker’s revenue came in above estimates as well. Herman Miller gave a lower-than-expected earnings forecast, however, and its shares fell 1.7% in the premarket.Jefferies Financial (JEF) – Jefferies beat Wall Street forecasts for both profit and revenue for its latest quarter, and the financial services firm also announced a 25% dividend increase. Jefferies rallied 3.3% in premarket trading.XPO Logistics (XPO) – XPO announced that its public offering of 5 million common shares was priced at $138 per share, compared to Monday’s close of $140.61. The transportation and logistics company plans to use the funds to pay down debt and for general corporate purposes. XPO fell 1.5% in the premarket.Herbalife Nutrition (HLF) – Herbalife was rated “buy” in new coverage at B Riley Securities, with a price target of $70 per share. The nutritional products maker’s stock closed at $53.34 on Monday. B Riley notes Herbalife’s global leadership in weight management supplements as an increasing presence in the sports/fitness category.General Electric (GE) – Goldman Sachs named the stock a “top idea,” based in part on an upbeat view of GE’s cash flow prospects as the industrials sector recovers. Goldman rates GE “buy” with a price target of $16 compared to Monday’s close of $12.89. GE rose 1% in premarket trading.Textron (TXT) – Textron was upgraded to “overweight” from “equal-weight” at Morgan Stanley, based on a rebound in the use of business jets as well as the prospects for electric vertical takeoff and landing vehicles.FedEx (FDX) – Bank of America Securities added FedEx to its “US1” list of top picks, while maintaining a “buy” rating. BofA sees significant tailwinds for FedEx including increased pricing power, and notes that the stock is at the low end of its historical trading range. More

  • in

    Morgan Stanley doubles its dividend as most banks raise payouts following Fed stress tests

    Morgan Stanley, the Wall Street powerhouse, doubled its quarterly dividend and announced a new $12 billion stock repurchase plan.The bank said Monday in a press release that its dividend will jump to 70 cents a share starting in the third quarter, and it would buy up to $12 billion of its own stock through June 2022. Shares of Morgan Stanley popped almost 4% in after-hours trading.”Morgan Stanley has accumulated significant excess capital over the past several years and now has one of the largest capital buffers in the industry,” CEO James Gorman said in the release. “The action taken by the Board reflects a decision to reset our capital base consistent with the needs we have for our transformed business model.”Morgan Stanley’s new capital plan appeared to be among the most aggressive of the banks rushing to announce at the market close. Larger rival JPMorgan Chase boosted its dividend by 11% to $1 per share, according to the bank. JPMorgan said it “continues to be authorized” to tap an existing share repurchase plan.Bank of America said its dividend would rise 17% to 21 cents. In April, the bank announced a $25 billion share repurchase plan. Goldman Sachs said it planned on boosting its dividend by 60% to $2 per share, subject to approval from the bank’s board.Wells Fargo said it plans on doubling its dividend to 20 cents a shares, subject to board approval. It also announced an $18 billion stock repurchase plan beginning in the third quarter. The firm’s dividend increase was widely expected by analysts because it was one of the only banks forced to slash its payout after last year’s stress test.  Meanwhile, Citigroup released a statement from CEO Jane Fraser that did not commit to any specific increases. Unlike the other firms, Citi also said its stress capital buffer requirement will increase this year, which may have reduced its ability to boost capital return. Shares of the bank dipped almost 1%.”We look forward to continuing with our planned capital actions, including common dividends of at least $0.51 per share, and to continuing share repurchases, which are particularly attractive when our stock price is below tangible book value per share,” Fraser said in the statement.Last week, the Federal Reserve announced that all 23 banks that took the 2021 stress test passed, with the industry “well above” required capital levels in a hypothetical economic downturn. While the institutions would post $474 billion in losses in this scenario, loss-cushioning capital would still be more than double the minimum required levels.The test was a key milestone for American banks, coming in the year after a global pandemic threatened to put the industry through a real-life stress test. After playing a key role in the 2008 financial crisis, banks were forced to undergo the annual ritual, and had to ask regulators for permission to boost dividends and repurchase shares.Now banks reclaim flexibility in how they choose to dole out capital in the form of dividends and buybacks. As long as they maintain capital levels above something called the stress capital buffer, banks can make more of their own decisions. The new regime was supposed to start last year, but the pandemic intervened.While analysts have said bank investors have mostly factored in higher payouts from banks, bigger-than-expected capital plans were still viewed favorably.Become a smarter investor with CNBC Pro. Get stock picks, analyst calls, exclusive interviews and access to CNBC TV. Sign up to start a free trial today. More

  • in

    How to assess the costs and benefits of lockdowns

    “TO ME, I say the cost of a human life is priceless, period,” said Andrew Cuomo, the governor of New York state. In the spring of 2020 politicians took actions that were unprecedented in their scale and scope as they tried to slow the spread of covid-19. The dire warnings of the deaths to come if nothing was done, and the sight of overflowing Italian hospitals, were unfamiliar and terrifying. Before the crisis the notion of halting people’s day-to-day activity seemed so economically and politically costly as to be implausible. But once China and Italy imposed lockdowns, they became unavoidable elsewhere.Much of the public debate over covid-19 has echoed Mr Cuomo’s refusal to think through the uncomfortable calculus between saving lives and the economy. To oversimplify just a little, the two sides of the lockdown debate hold diametrically opposed and equally unconvincing positions. Both reject the idea of a trade-off between lives and livelihoods. Those who support lockdowns say that they have had few malign economic effects, because people were already so fearful that they avoided public spaces without needing to be told. They therefore credit the policy with saving lives but do not blame it for wrecking the economy. Those who hate lockdowns say the opposite: that they destroyed livelihoods but did little to prevent the virus spreading.The reality lies between these two extremes. Lockdowns both damage the economy and save lives, and governments have had to strike a balance between the two. Were trillions of dollars of lost economic output an acceptable price to pay to have slowed transmission? Or, with around 10m people dead, should the authorities have clamped down even harder? With politicians considering whether and when to lift existing restrictions, or to impose new ones, the answers to these questions are still crucial for policy today. Alongside vaccines, lockdowns remain an important way of coping with new variants and localised outbreaks. In late June Sydney went into lockdown for two weeks; Indonesia, South Africa and parts of Russia have followed suit.Countries have employed a number of measures to restrict social mixing over the past year, from stopping people visiting bars and restaurants to ordering mask-wearing. The extent to which these strictures have constrained life has varied widely across countries and over time (see chart 1). A growing body of economic research explores the trade-off between lives and livelihoods associated with such policies. Economists have also compared the costs of lockdowns with estimates of its benefits. But whether the costs are worth incurring is a matter for debate not just among wonks, but for society at large.People who see no trade-off at all might start by pointing to a study of the Spanish flu outbreak in America in 1918-20 by Sergio Correia, Stephan Luck and Emil Verner, which suggested that cities that enacted social distancing earlier may have ended up with better economic outcomes, perhaps because business could resume with the pandemic under control. But other economists have criticised the paper’s methodology. Cities with economies that were doing better before the pandemic, they say, happened to implement restrictions earlier. So it is unsurprising that they also did better afterwards. (The authors of the original paper note that pre-existing trends are “a concern”, but that “our original conclusion that there is no obvious trade-off between ‘flattening the curve’ and economic activity is largely robust.”)Another plank of the no-trade-off argument is the present-day experience of a handful of places. Countries such as Australia and New Zealand followed a strategy of eliminating the virus, by locking down when recorded infections rose even to low levels, and imposing tough border controls. “Covid-19 deaths per 1m population in OECD countries that opted for elimination…have been about 25 times lower than in other OECD countries that favoured mitigation”, while “GDP growth returned to pre-pandemic levels in early 2021 in the five countries that opted for elimination”, argues a recent paper in the Lancet. The lesson seems to be that elimination allows the economy to restart and people to move about without fear.Counterfactual controversiesBut correlations do not tell you much. Such countries’ success so far may say more about good fortune than it does about enlightened policy. What was available to islands such as Australia, Iceland and New Zealand was not possible for most countries, which have land borders (and once the virus was spreading widely, eradication was almost impossible). Japan and South Korea have seen very low deaths from covid-19 and are also cited by the Lancet paper as having pursued elimination. But whether they did so or not is questionable: neither country imposed harsh lockdowns. Perhaps instead their experience with the SARS epidemic in the early 2000s helped them escape relatively unscathed.When you look at more comparable cases—countries that are close together, say, or different parts of the same country—the notion that there is no trade-off between lives and livelihoods becomes less credible. Research by Goldman Sachs, a bank, shows a remarkably consistent relationship between the severity of lockdowns and the hit to output: moving from France’s peak lockdown (strict) to Italy’s peak (extremely strict) is associated with a decline in GDP of about 3%. Countries in the euro area with more excess deaths as measured by The Economist are seeing a smaller hit to output: in Finland, which has had one of the smallest rises in excess deaths in the club, GDP per person will fall by 1% in 2019-21, according to the IMF; but in Lithuania, the worst-performing member in terms of excess deaths, GDP per person will rise by more than 2%.The experience across American states also hints at the existence of a trade-off. South Dakota, which imposed neither a lockdown nor mask-wearing, has done poorly in terms of deaths but its economy, on most measures, is faring better today than it was before the pandemic. Migration patterns also tell you something. There have been plenty of stories in recent months about people moving to Florida (a low-restriction state) and few about people going to Vermont (the state with the fewest deaths from covid-19 per person, after Hawaii), points out Tyler Cowen of George Mason University. Americans, at least, do not always believe that efforts to control covid-19 make life more worth living.What if all these economic costs are the result not of government restrictions, though, but of personal choice? This too is argued by those who reject the idea of a trade-off. If they are correct, then the notion that simply lifting restrictions can boost the economy becomes a fantasy. People will only go out and about when cases are low; if they start rising, then people will shut themselves away again.A number of papers have bolstered this argument. The most influential, by Austan Goolsbee and Chad Syverson, two economists, analyses mobility along administrative boundaries in America, at a time when one government imposed restrictions but the other did not. It finds that people on either side of the border behaved similarly, suggesting that it was almost entirely personal choice, rather than government orders, which explains their decision to limit social contact: people may have taken fright when they heard of local deaths from the virus. Research by the IMF draws similar conclusions.There are reasons to think these findings overstate the power of voluntary behaviour, however. Sweden, which had long resisted imposing lockdowns, eventually did so when cases rose—an admission that they do make a difference. More recent research from Laurence Boone of the OECD, a rich-country think-tank, and Colombe Ladreit of Bocconi University uses slightly different measures from the IMF and finds that government orders do rather a lot to explain behavioural change.Moreover, the line between compulsion and voluntary actions is more blurred than most analysis assumes. People’s choices are influenced both by social pressure and by economics. Press conferences where public-health officials or prime ministers warn about the dangers of the virus do not count as “mandated” restrictions on movement; but by design they have a large effect on behaviour. And in the pandemic certain voluntary decisions had to be enabled by the government. Topped-up unemployment benefits and furlough schemes made it easier for people to choose not to go to work, for instance.Put this all together and it seems clear that governments’ actions did indeed get people to stay at home, with costly consequences for the economy. But were the benefits worth the costs? Economic research on this question tries to resolve three uncertainties: over estimates of the costs of lockdowns; over their benefits; and, when weighing up the two, over how to put a price on life—doing what Mr Cuomo refused to do.Vital statisticsStart with the costs. The huge collateral damage of lockdowns is becoming clear. Global unemployment has spiked. Hundreds of millions of children have missed school, often for months. Families have been kept apart. And much of the damage is still to come. A recent paper by Francesco Bianchi, Giada Bianchi and Dongho Song suggests that the rise in American unemployment in 2020 will lead to 800,000 additional deaths over the next 15 years, a not inconsiderable share of American deaths from covid-19 that have been plausibly averted by lockdowns. A new paper published by America’s National Bureau of Economic Research (NBER) expects that in poor countries, where the population is relatively young, “a lockdown can potentially lead to 1.76 children’s lives lost due to the economic contraction per covid-19 fatality averted”, probably because wellbeing suffers as incomes decline.Researchers are more divided over the second uncertainty, the benefit of lockdowns, or the extent to which they reduce the spread of covid-19. The fact that, time and again, the imposition of a lockdown in a country was followed a few weeks later by declining cases and deaths might appear to settle the debate. That said, a recent NBER paper failed to find that countries or American states that implemented shelter-in-place policies earlier had fewer excess deaths than places which were slower to implement such restrictions. Another paper published in PNAS, a scientific journal, by Christopher Berry of the University of Chicago and colleagues, cannot find “effects of [shelter-in-place] policies on disease spread or deaths”, but does “find small, delayed effects on unemployment”.Is the price right?Running through this all is the final uncertainty, over putting a price on life. That practice might seem cold-hearted but is necessary for lots of public policies. How much should governments pay to make sure that bridges don’t collapse? How should families be compensated for the wrongful death of a relative? There are different ways to calculate the value of a statistical life (VSL). Some estimates are derived from the extra compensation that people accept in order to take certain risks (say, the amount of extra pay for those doing dangerous jobs), others from surveys.Cost-benefit analyses have become a cottage industry during the pandemic, and their conclusions vary wildly. One paper by a team at Yale University and Imperial College, London, finds that social distancing, by preventing some deaths, provides benefits to rich countries in the region of 20% of GDP—a huge figure that plausibly exceeds even the gloomiest estimates of the collateral damage of lockdowns. But research by David Miles, also of Imperial College, and colleagues finds that the costs of Britain’s lockdown between March and June 2020 were vastly greater than their estimates of the benefits in terms of lives saved.An important reason for the big differences in cost-benefit calculations is disagreement over the VSL. Many rely on a blanket estimate that applies to all ages equally, which American regulatory agencies deem is about $11m. At the other extreme Mr Miles follows convention in Britain, which says that the value of one quality-adjusted life-year (QALY) is equal to £30,000 (which seems close to a VSL of around £300,000, or $417,000, given how many years of life the typical person dying of covid-19 loses). The lower the monetary value you place on lives, the less good lockdowns do by saving them.The appropriate way to value a change in the risk of death or life expectancy is subject to debate. Mr Miles’s number does, however, look low. In Britain the government’s “end-of-life” guidance allows treatments that are expected to increase life expectancy by one QALY to cost up to £50,000, points out Adrian Kent of Cambridge University in a recent paper, and allows a threshold of up to £300,000 per QALY for treating rare diseases. But it may be equally problematic to use the average figure of $11m in the case of the covid-19 pandemic, which disproportionately affects the elderly. The death of a frail 92-year-old is probably not as tragic as the death of a healthy 23-year-old. Because older people have fewer expected years left than the average person, researchers may choose to use lower estimates of VSL.The best attempt at weighing up these competing valuations is a recent paper by Lisa Robinson of Harvard University and colleagues, which assesses what happens to the results of three influential cost-benefit studies of lockdowns when estimates of the VSL are altered (see chart 2). Adjusting for age can sharply reduce the net benefits of lockdowns, and can even lead to a result where “the policy no longer appears cost-beneficial”. Given that these models do not take into account the harder-to-measure costs of lockdowns—how to price the damage caused by someone not being able to attend a family Christmas, say, or a friend’s funeral?—the question of whether they were worth it starts to look like more of a toss-up.But things only become still more complicated once you open the door to adjustments. Research on risk perception finds that uncertainty and dread over an especially bad outcome, especially one that involves more suffering before death, mean that people may be willing to pay far more to avoid dying from it. People appear to value not dying from cancer far more than not dying in a road accident, for instance. Many went to extraordinary lengths to avoid contracting covid-19, suggesting that they place enormous value on not dying from that disease. Some evidence suggests that the VSL might need to be increased by a factor of two or more, writes James Hammitt, also of Harvard, in a recent paper. That adjustment could make lockdowns look very worthwhile.The malleability of cost-benefit analysis itself hints at the true answer of whether or not lockdowns were worth it. The benefit of a saved life is not a given but emerges from changing social norms and perceptions. What may have seemed worthwhile at the height of the pandemic may look different with the benefit of hindsight. Judgments over whether or not lockdowns made sense will be shaped by how society and politics evolve over the coming years—whether there is a backlash against the people who imposed lockdowns, whether they are feted, or whether the world moves on. More

  • in

    This under-the-radar trend may provide investors with relief from runaway inflation fears

    A longtime market bull sees an under-the-radar trend that should calm runaway inflation fears, and it has nothing to do with Federal Reserve policy.According to The Leuthold Group’s Jim Paulsen, private money coming from individuals and companies has been acting as a “very encouraging” market mechanism to help curb inflation.”We make decisions about whether we save or spend. We make decisions on whether we borrow money or not. And, those all affect the rate of growth of the money supply,” the firm’s chief investment strategist told CNBC’s “Trading Nation” on Monday. “While we’re still debating when the Fed may start tapering … the reality is the money supply in this country has been tapering now for the last four months.”Paulsen, who oversees about $1 billion in assets, highlights the trend in a special chart. It shows the relationship between consumer price inflation and money supply since 1990.Zoom In IconArrows pointing outwards”The real M2 money supply [total amount of dollars held by the public] peaked at the end of February year-on-year at 26% rate of growth,” Paulsen said. “As of the end of May, it’s down to about 8.5%, and it’s probably lower than that when the June numbers come out.”Paulsen estimates it dropped the rate of growth and real liquidity by about a third.”When you overlay that real money supply chart on top of the inflation rate, it’s not a perfect relationship,” he noted. “But there is certainly a strong relationship where periods of significant declines in the money supply often lead into the future to slower rates of inflation.”What a difference two months makes.On “Trading Nation” in April, Paulsen ranked runaway inflation as his biggest risk to the market and put the probability of runaway inflation at around 40%. ‘Yields are about done going down’Despite his current optimism regarding mitigating inflation risks, Paulsen still expects the benchmark 10-year Treasury Note yield to climb higher. Yields closed at 1.48% on Monday, down more than 11% over the past three months.”Yields are about done going down. We’re going to continue to get really strong growth reports,” he added. “We’ve got another fiscal package coming, and I think that’s going to rejuvenate inflation fears and strong real GDP growth that’s going to push yields back up towards 2% by the end of the year.”His expectation: Higher yields will create headwinds for stocks, particularly for growth names, in the year’s second half.”People worry about monetary tightening, and the market goes through kind of a pausal period, and I think we’re in that right now,” said Paulsen. “Oftentimes during these periods we have corrections, and I think we may get one of those later this year as well.”He predicts the S&P 500 will hit 4,500 before slumping to 4,100 by year-end. On Monday, it closed at 4,290.61 — an all-time high. It’s up 14% so far this year.”[If] the market ends flattish or a little down from where we are now, we’re going to go into 2022 with a stock market, with a trailing P/E multiple, that’s undervalued relative to its history back to 1990,” Paulsen said. “It sets up the next leg of the bull.”Disclaimer More

  • in

    Stock futures are flat after S&P 500 closes at a record

    U.S. stock index futures were little changed during overnight trading on Monday, after the S&P 500 and Nasdaq Composite closed at record highs.Futures contracts tied to the Dow Jones Industrial Average were flat. S&P 500 futures were also flat, while Nasdaq 100 futures dipped 0.1%.Stocks rose to new highs during regular trading on Monday amid strength in Big Tech. The S&P 500 advanced 0.23%, registering its third straight record close. The Nasdaq gained nearly 1%, posting its fifth positive session in the last six, and also closed at a new high. The Dow, however, dipped 151 points amid a pullback in Boeing and Chevron, among other names.”Markets are off to a strong start this year,” LPL Financial chief market strategist Ryan Detrick said. “However, most of those gains came early in the year, and many stocks have stagnated over recent months,” he added. Detrick believes investors should stay overweight stocks relative to bonds, but pointed to some concerns in the market, including elevated valuations.Growth stocks continued to outperform on Monday, with the Russell 1000 rising nearly 1% while its value counterpart finished in the red. The value trade was outperforming for much of the year, but recently investors have rotated back into growth-oriented areas of the market. These stocks are up 6% for June, while value’s down more than 1%.”The breakout to new highs in Growth was the catalyst to push the S&P 500 to new highs,” MKM Partners chief market technician JC O’Hara noted. “We see the situation where Growth may continue to outperform Value in the weeks ahead,” he said, based on technical analysis.Shares of Morgan Stanley advanced 3% during extended trading after the company said it will double its quarterly dividend. The bank also announced a $12 billion stock buy back program. The announcement follows last week’s stress tests by the Federal Reserve, which all 23 banks tested passed.Bank of America, Goldman Sachs and JPMorgan also announced dividend increases.With the market entering the final trading days of June and the second quarter, the S&P 500 is on track to register its fifth straight month of gains. The Nasdaq is pacing for its seventh positive month in the last eight. The Dow, however, is in the red for the month, and on track to snap a four-month winning streak.Become a smarter investor with CNBC Pro. Get stock picks, analyst calls, exclusive interviews and access to CNBC TV. Sign up to start a free trial today More

  • in

    Fed Vice Chair Quarles casts significant doubt on establishing a digital dollar

    Randal QuarlesHailey Lee | CNBCWith the Federal Reserve set to release a much-anticipated report this summer on the potential creation of a digital dollar, the central bank’s vice chair for supervision said Monday that he has significant doubts about the idea.Fed Governor Randal Quarles expressed skepticism about most arguments made in favor of a central bank digital currency.”The potential benefits of a Federal Reserve CBDC are unclear,” Quarles said in prepared remarks to the Utah Bankers Association. “Conversely, a Federal Reserve CBDC could pose significant and concrete risks.”Among the downsides he cited are the challenges if the public could bypass traditional banks and go straight to the Fed for digital money. Along the same lines, he said the benefits that consumers get through bank competition might be diminished if the Fed stepped further into the space.Also, he worried about the potential for cyberattacks on a system whose security would be difficult to design.Proponents of a Fed-issued digital dollar say it could speed up payments systems, particularly internationally. They also cite the benefits for the unbanked or underbanked who don’t have access to the existing digital payments system.Richmond Fed President Thomas Barkin also expressed doubt about the digital dollar. “We already have a digital currency in this country, it’s called the dollar,” Barkin said in Atlanta. “So if you’re gonna enhance the digital currency, you have to decide for what reason … I still haven’t heard a good story about what we’re trying to accomplish.””Essentially, a Fed digital currency would act the same as the digital dollars that are exchanged every day, except instead of being guaranteed by banks they would be backed by the Fed. Those who don’t have bank accounts could use the Fed system to transfer money back and forth. Advocates say, for example, that getting stimulus checks out to people during crises like the Covid-19 pandemic would be made easier through a central bank digital currency system.But Quarles said the system could be difficult and expensive to design, likely would require an act of Congress and would be redundant for the systems already in place.”First, the U.S. dollar payment system is very good, and it is getting better. Second, the potential benefits of a Federal Reserve CBDC are unclear. Third, developing a CBDC could, I believe, pose considerable risks,” he said. “So, our work is cut out for us as we proceed to rigorously evaluate the case for developing a Federal Reserve CBDC.”His remarks come with the Fed set to release a research paper this summer to explore the issue further. Some other Fed officials, such as Governor Lael Brainard, have expressed support for the CBDC.In announcing the study, Fed Chairman Jerome Powell said in May that the “focus is on ensuring a safe and efficient payment system that provides broad benefits to American households and businesses while also embracing innovation.”CBDC advocates worry that the Fed could lose its place in the global financial system if it doesn’t keep up in the space, with the hegemony of the U.S. dollar as the world’s reserve currency ultimately coming under threat.But Quarles said that it “seems unlikely” that any real threat to the American currency could emerge thanks to its relatively stable value, continued importance in global financial markets, and the depth and systemic importance of Treasurys and the greenback.”None of these are likely to be threatened by a foreign currency, and certainly not because that foreign currency is a CBDC,” he said.Quarles also said he sees little threat from cryptocurrencies like bitcoin, which have been likened to gold in terms of safe havens against instability and inflation.”Gold will always glitter, but novelty, by definition, fades,” he said. “Bitcoin and its ilk will, accordingly, almost certainly remain a risky and speculative investment rather than a revolutionary means of payment, and they are therefore highly unlikely to affect the role of the U.S. dollar or require a response with a CBDC.”Quarles said he sees the process involved with the Fed research as “genuinely open” and “without a foregone conclusion,” though in his view the “bar to establishing a U.S. CBDC is a high one.””As we begin our Fed analysis of these issues, I will have to be convinced that a CBDC is a particularly good tool to address either of these issues, about which I am skeptical, and I will especially have to be convinced that the potential benefits of developing a Federal Reserve CBDC outweigh the potential risks,” he said.Become a smarter investor with CNBC Pro.Get stock picks, analyst calls, exclusive interviews and access to CNBC TV.Sign up to start a free trial today. More

  • in

    Perella Weinberg shares popped and later cooled after going public last week via a SPAC

    In this articlePWPPerella Weinberg shares saw a sharp rise early Monday after going public last week via a SPAC. The stock opened 12% higher Monday, before bouncing between positive and negative territory later in the day. It closed down 0.7% at $12.91 per share. The global investment bank — headquartered in New York City — started trading Friday after announcing the day before that it completed its merger with special purpose acquisition company FinTech Acquisition Corp. IV.”We’re going public because we think there’s a very significant growth opportunity for the firm going forward,” co-founder and CEO Peter Weinberg said Monday on CNBC’s “Squawk Box.””The reason that we picked a SPAC is because it’s a transaction as opposed to a process” like an initial public offering, said Weinberg, who prior to starting his own firm was CEO of Goldman Sachs International in London. “Given all the constituencies that we have, our founding investors, our retired partners — very important constituencies for us — it was easier and better to have a SPAC,” which earlier this year was a red-hot asset class.However, the craze, coupled with a recent slump of SPAC shares, may lead to riskier deals in upcoming months and years, according to observers.”Any option you pick, you’re going to end up as a public company,” Weinberg said. “A lot of the issues surrounding SPACs have been less about the structure and more about the companies sometimes that were unprepared to be public.”Weinberg said he’s not worried about how the decision to go public will affect his firm, which he started with fellow dealmaker Joe Perella in 2006. Prior to that, Perella, now chairman emeritus at their firm, held several senior positions at Morgan Stanley.The merger environment right now is “extremely active,” Weinberg said, anticipating an enormous amount of change to occur within many different industry groups from consumer health care to energy. He added that while the confidence levels are very high, chief executives are feeling an enormous pressure to create value and to outperform their competitors.”I think what’s going to happen in the SPAC space is that there should be a level playing field when you look at an IPO and when you look at a SPAC, particularly as it relates to projections. We’re still in the early stages of this round two of SPACs, and so I think that’ll happen,” Weinberg said. “But the important thing really is that two years after the event, you’re probably going to have the identical shareholders. It’s just a different route to the same destination.” More

  • in

    Stocks making the biggest moves midday: Boeing, Intellia Therapeutics, Royal Caribbean and more

    In this article.AD.IXICCheck out the companies making headlines in midday trading.Intellia Therapeutics – Intellia shares surged 50% after the company announced positive results from a phase one study, along with partner Regeneron, of a gene-editing treatment. The treatment is the first time gene-editing technique CRISPR has been delivered systemically as a medicine to the human body. Other companies involved with CRISPR also saw their shares rally, with CRISPR Therapeutics’ stock soaring 6.4% and Editas Medicine’s stock jumping 5%.Boeing — Shares fell 3.4% after the Federal Aviation Administration said in a letter to the aircraft maker that its 777X long-range aircraft likely won’t be approved to fly until mid- to late-2023 at the earliest. The FAA’s letter to Boeing, which was obtained by CNBC, said there were numerous technical issues that needed to be resolved.Cruise stocks — Cruises may be back, but cruise line stocks are falling after two teenage guests on one of Royal Caribbean’s ships tested positive for Covid-19. Royal Caribbean traded 6.4% lower Monday, while Carnival fell 7% and Norwegian Cruise dropped 6%.Oil stocks — Oil names fell as West Texas Intermediate crude oil futures dipped Monday after gaining more than 10% in June. Occidental Petroleum erased 5%, Marathon Oil dropped 4.8%, Devon Energy shed 4.5% and Chevron fell 3% lower.Tesla — Shares gained 2.5% after Wedbush said the company faces a “moment of truth” following an autopilot software recall in China. The firm maintained its outperform rating on the electric vehicle maker despite the negative headlines.Nvidia — The semiconductor maker saw its equity jump 5% after it received support for its planned $40 billion takeover of U.K.-based chip designer Arm, according to a report in the Sunday Times of London. The public display of support comes from Broadcom, Marvell and MediaTek, all of which are customers of Arm.NRG Energy — The utility stock jumped more than 6% after Goldman Sachs added NRG Energy to its conviction list. The firm said in a note to clients that NRG’s strong cash flow profile could enable the company to buy back nearly a quarter of its shares.Perion Network — Shares jumped 17% after the Israel-based ad-tech company reported better-than-expected preliminary second-quarter results. The company reported preliminary second-quarter revenue of $105 million, compared with analysts’ projection of $95.9 million, according to FactSet.Bed Bath & Beyond — The retailer’s stock traded more than 5.9% higher after CFRA Research upgraded it to a buy rating from hold. CFRA said it’s maintaining a $40 price target, implying almost 40% upside.— CNBC’s Jesse Pound, Tom Franck and Tanaya Macheel contributed reportingBecome a smarter investor with CNBC Pro. Get stock picks, analyst calls, exclusive interviews and access to CNBC TV. Sign up to start a free trial today More